The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Sakaniia L.R.

Pervyĭ MGMU im. I.M. Sechenova

Plteva K.T.

FGBUN «Tsentr teoreticheskih problem fiziko-himicheskoj farmakologii Rossijskoj akademii nauk», Moskva, Rossija, 119991

Korsunskaia I.M.

Centre of Theoretical Problems of Physico-Chemical Pharmacology, Russian Academy of Sciences

Using algorithm of descending doses of retinoids in treatment of acne resistant to standard therapies

Authors:

Sakaniia L.R., Plteva K.T., Korsunskaia I.M.

More about the authors

Read: 60765 times


To cite this article:

Sakaniia LR, Plteva KT, Korsunskaia IM. Using algorithm of descending doses of retinoids in treatment of acne resistant to standard therapies. Russian Journal of Clinical Dermatology and Venereology. 2016;15(2):72‑76. (In Russ.)
https://doi.org/10.17116/klinderma201615272-76

Recommended articles:
Hidradenitis suppurativa: a clinical case. Russian Journal of Clinical Dermatology and Vene­reology. 2024;(5):542-545
Anti-Inflammatory Effe­cts of Cold Atmo­spheric Plasma in the Mono­therapy of Mode­rate Acne. Russian Journal of Clinical Dermatology and Vene­reology. 2024;(6):720-723
Asse­ssment of Cream with Conjugated Hyaluronidase Effe­ctiveness in the Correction of Post-Acne Syndrome. Russian Journal of Clinical Dermatology and Vene­reology. 2024;(6):766-775
Clinical features of severe acne and gene­tic dete­rminants of therapeutic effi­cacy of systemic isotretinoin. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(1):30-37
Dissecting cellulitis of the scalp (Hoffman’s disease): a clinical case. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(1):45-48
Study of the role of inte­rleukin-1β in blood serum in patients with acne. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(4):421-424
Adhe­rence of patients to acne therapy using systemic isotretinoin. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(4):483-488

References:

  1. IO Smirnova, MA Karachevceva, SM Mihajlov, EA Kulikova, IS Kolova, TS Smirnova, VJu Dudko, JaG Petunova, NV. Shin. Medical care to patients with acne. The results of examination of the quality of care. Vestn dermatol venerol. 2015; 1: 76-84. (In Russ)
  2. Goodfield MJ, Cox NH, Bowser A. Advice on the safe introduction and continued use of isotretinoin in acne in the U. K.. Br. J. Dermatol. 2010; 162 (6): 1172 – 1179.
  3. Sardana K, Garg VK. Efficacy of low-dose isotretinoin in acne vulgaris. Indian J. Dermatol. Venereol. Leprol. 2010; 76 (1): 7 – 13.
  4. Ingram JR, Grindlay DJ, Williams HC. Management of acne vulgaris: an evidence-based update. Clin. Exp. Dermatol. 2010; 35 (4): 351 – 354.
  5. Berbis P. Systemic retinoids (acitretin, isotretinoin). Ann. Dermatol. Venereol. 2007; 134 (12): 935 – 941.
  6. Samgin MA, Monahov SA. New development in the pathogenesis and topical therapy of acne. Vestn dermatol venerol. 2003; 2: 31-8. (In Russ)
  7. Bikers DR. Is isotretinoin a precursor? New results from experimental studies. Data of symposium «New perspectives in the therapy with oral isotretinoin» by F.Hoffman-La Roche. Paris; 2002.
  8. Levin AA, Sturzenbecker LJ, Kazmer S, Bosakowski T, Huselton C, Allenby G, et al. 9-cis retinoic acid stereoisomer binds and activates the nuclear receptor RXR alpha. Nature. 1992; 355(6358): 359-61.
  9. Samgin MA, L'vov AN, Potekaev NS, Potekaev NN, Mazaeva SV, Gromova SA. New possibilities in the treatment of rosacea and sebaceous gland diseases.. Ros zhurn kozh ven bol. 2002; 3: 60-5. (In Russ)
  10. Chu A, Cunliffe WJ. The inter-relationship between isotretinoin/ acne and depression. J. Eur. Acad. Dermatol. Venereol. 1999; 12(3): 263.
  11. L'vov AN, Kiriljuk AV. Roaccutane® in treatment of acne: the standard therapeutic regimens and a new low dose regimen. Rus med zhurn. 2008; 23: 1541-6. (In Russ)
  12. Kubanova AA. Klinicheskie rekomendacii po vedeniju bol'nyh akne. M.: Djeks-Press; 2010. (In Russ)
  13. Cunliffe WJ, van de Kerkhof PC, Caputo R, Cavicchini S, Cooper A, Fyrand OL, et al. Roaccutane treatment guidelines: results of an international survey. Dermatol. 1997; 194: 351-7.
  14. Samgin MA, Gromova SA, Kolesnikov JuJu. Roaccutane in the therapy of severe manifestations of acne vulgaris and rosacea. Vestn dermatol venerol. 1989; 12: 56-60. (In Russ)
  15. Korchevaja TA, Ahtjamov SN, Aravijskaja EA, Olisova OJu, Peskova IV, Polonskaja NA, Sokolovskij EV. The use of small doses of Roaccutane in treatment of acne. Plasticheskaja hirurgija i kosmetologija 2012; 1: 132-40. (In Russ)
  16. Hirsch RJ, Shalita AR. Isotretinoin dosing: past, present, and future trends. Semin Cutan. Med. Surg. 2001; 20(3): 162-5.
  17. Goulden V, Layton AM, Cunliffe WJ. Long-term safety of isotretinoin as a treatment for acne vulgaris. Br. J. Dermatol. 1994; 131(3): 360-3.
  18. Falk ES, Stenvold SE. Long-term effects of isotretinoin inthe treatment of severe nodulocystic acne. Riv. Eur. Sci. Med. Farmacol. 1992; 14(4): 215-20
  19. Geiger JM, Hommel L, Harms M, Saurat JH. Oral 13-cis retinoic acid is superior to 9-cis retinoic acid in sebosuppression in human beings. J. Am. Acad. Dermatol. 1996; 34: 513-5.
  20. Jones DH, Cunliffe WJ, Löffl er A. A comparative study on 13-cis-retinoic acid and erythromycin therapy in severe acne. Lancaster: MTP Press; 1984: 293-301.
  21. Strauss JS, Stranieri AM, Farrell LN, Downing DT. The effect of marked inhibition of sebum production with 13-cis-retinoic acid on skin surface lipid composition. J. Invest. Dermatol. 1980; 74: 66-7.
  22. Sardana K, Garg VK, Sehgal VN, Mahajan S, Bhushan P. Effi cacy of fi xed low-dose isotretinoin (20 mg, alternate days) with topical clindamycin gel in moderately severe acne vulgaris. J Eur Acad Dermatol Venereol. 2009; 23(5): 556-60.
  23. Borghi A, Mantovani L, Minghetti S, Giari S, Virgili A, Bettoli V. Low-cumulative dose isotretinoin treatment in mild-to-moderate acne: effi cacy in achieving stable remission. J. Eur. Acad. Dermatol. Venereol. 2011; 25(9): 1094-8.
  24. Akne: klinicheskie rekomendacii Rossijskogo obshhestva dermatologov, pod. Red. A.A. Kubanovoj, M.: DJeKS- Press, 2010. (In Russ)
  25. Samcov AV. Akne i akneformnyj dermatozy M., 2009. (In Russ)
  26. Bakulev AL, Kravchenja SS, Platonova AN, Igonina IA., Long-term treatment of patients with severe acne: adjustment of doses and regimens of administration of systemic isotretinoin. Vestn dermatol venerol. 2014; 1: 1-9. (In Russ)
  27. RLS 2015 [electronic source], http://www.rlsnet.ru.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.